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Abstract: (1) Background: My Health Record (MHR) is a relatively new nationwide Australian digital
health record system accessible by patients and a range of healthcare professionals. Pharmacists will
be key contributors and users of the MHR system, yet little is known about the perceived barriers and
benefits of use. (2) Objective: To explore pharmacists’ perspectives related to potential benefits and
barriers associated with use of MHR. (3) Methods: An online survey was developed and face-validated.
The survey was advertised to Australian pharmacists on pharmacy professional bodies’ websites. This
was a cross-sectional study using an anonymous questionnaire. Descriptive statistics were used to
describe the distribution of the data. Chi-square, Kendall’s tau coefficient (tau-c) and Kruskal–Wallis
tests were used to examine the relationships where appropriate. (4) Results: A total of 63 pharmacists
completed the survey. The majority of respondents worked in a metropolitan area (74%), and the
most common workplace setting was community pharmacy (65%). Perceived benefits identified
by responders include that the use of MHR would help with continuity of care (90%), and that it
would improve the safety (71%) and quality (75%) of care they provided. Importantly, more than
half of pharmacists surveyed agreed that MHR could reduce medication errors during dispensing
(57%) and could improve professional relationships with patients (57%) and general practitioners
(59%). Potential barriers identified by pharmacists included patients’ concerns about privacy (81%),
pharmacists’ own concern about privacy (46%), lack of training, access to and confidence in using the
system. Sixty six percent of respondents had concerns about the accuracy of information contained
within MHR, particularly among hospital and general practice pharmacists (p = 0.016) and almost
half (44%) had concerns about the security of information in the system, mainly pharmacists working
at general practice and providing medication review services (p = 0.007). Overall satisfaction with
MHR varied, with 48% satisfied, 33% neither satisfied nor dissatisfied, and 19% dissatisfied, with
a higher satisfaction rate among younger pharmacists (p = 0.032). (5) Conclusions: Pharmacists
considered that the MHR offered key potential benefits, notably improving the safety and quality of
care provided. To optimize the use of MHR, there is a need to improve privacy and data security
measures, and to ensure adequate provision of user support and education surrounding the ability to
integrate use of MHR with existing workflows and software.
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1. Introduction
Advancements in information technology have numerous potential applications in healthcare,
including the adoption of electronic health records (EHRs) in several countries [1–3]. According to the
World Health Organization, more than 50% of upper-middle and high-income countries (e.g., countries
in North America and Europe) have adopted national EHR systems [4].The Australian Government
initially introduced shared personally-controlled EHRs in 2012; these were relaunched and renamed in
2016 as My Health Record (MHR). MHR aims to improve the safety and efficiency of healthcare by
reducing the potential for medical errors, facilitating collaboration among health professionals and
encouraging patient participation and engagement through individual access to a summary of their
clinical records [5–7]. Australian MHR contains a summary of an individual’s health information
such as list of medical conditions, medications, pathology tests or scans results, hospital discharge
notes, immunization records and organ donation decisions. Patients can also update their information.
Health professionals can upload relevant medical documents such as shared health summary, medical
doctors’ consultation detail, pharmacists’ medication review notes and care plans [8].
The use of MHR in pharmacy is growing, with 83% of Australian pharmacies [9] (approximately
5700) [10] reportedly registered with access to the system, as of April 2019 [9]. The number of
pharmacies that actually use MHR routinely has not been reported to date; however, pharmacists’
use of MHR is expected to improve over time. This is likely to improve pharmacists’ access to
patient information, medication history, known allergies, medical conditions and hospital discharge
summaries, in a consolidated environment. Access to an integrated patient summary (shared health
summary) through MHR has the potential to improve quality of care, reduce medication-related
problems and improve interprofessional collaboration [9].
Achieving and utilising the full potential of MHR will require consumers and healthcare providers
to actively engage with the system; thus, greater understanding of the perspectives of user groups and
profession-specific barriers and benefits to the use of MHR is important. Previous studies have sought
to examine the attitudes of healthcare consumers [11–13] and a range of healthcare providers [13–16]
towards the use of personally-controlled EHRs, yet the unique perspectives of pharmacists as key
users of MHR have not been previously investigated. The expanded role of pharmacists in healthcare
delivery requires access to comprehensive patient records. Pharmacists in Australia conduct a variety
of clinical activities based on their practice settings that are commonly characterized as community,
hospital, consultant, industrial or academic pharmacists [17,18]. Pharmacists have frequent contact
with patients in community pharmacy settings and could play an important role in providing quality
information about medication therapies on EHRs [19]. This study aimed to gather the pharmacists’
perspectives about the benefits and barriers of using MHR in their professional role.
2. Methods
A survey questionnaire (Supplementary Materials) targeting Australian registered pharmacists
was developed that consisted of 5 domains: (i) characteristics of respondents and their frequency of use
of MHR; perceived (ii) benefits, (iii) barriers and (iv) concerns about the use of MHR; and (v) overall
satisfaction. Respondents were presented with a series of statements and asked to indicate either
strength of agreement or disagreement (ranging from ‘strongly agree’ to ‘strongly disagree’) or the
likelihood that the barrier would apply to them (ranging from ‘extremely likely’ to ‘extremely unlikely’)
using a 5-point Likert scale. A free-text box was provided for respondents to describe other barriers
to the use of MHR and characteristics of MHR that they believed required change or improvement.
The survey was face-validated by collaborators and registered pharmacists.
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The survey was simultaneously promoted through the following pharmacy-related newsletters
and websites: the Pharmacy Guild of Australia (website only), Pharmaceutical Society of Australia
(website only), Australian Association of Consultant Pharmacy (newsletter only), and the Australian
Journal of Pharmacy (newsletter and website). The survey was hosted/available on QUALTRICS
and was accessible for respondents between September 2018 and March 2019. A reminder was also
distributed through pharmacy professional bodies’ websites during this period.
Descriptive statistics were used to describe the distribution of the data. Categories of agreement
and disagreement (strongly, somewhat) and likelihood (extremely, somewhat) were collapsed to
improve interpretation in the text, while complete data is presented in table form. Analytical statistics
were performed when appropriate. Chi-square and Kendall’s tau coefficient (tau-c) tests were used to
examine the relationship between the ordinal data; and Kruskal–Wallis test was used to examine the
relationship between a nominal data vs ordinal data. Statistical analyses were performed using SPSS
version 25 (IBM, Armonk, NY, USA).
All participants provided their informed consent electronically before they participated in the
study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the University of Canberra Human Research Ethics Committee (approval number HREC
1510). This was an anonymous voluntary study and no identifiable information was collected.
3. Results
A total of 63 respondents from all Australian states and territories completed the online survey
with valid responses. The survey was conducted at an early stage of re-launch of MHR; there were
approximately 30,000 registered pharmacists in Australia in 2018 [20]; however, it is unknown how many
pharmacists actively used MHR or read the survey advertisement on pharmacy professional bodies.
Demographic characteristics are presented in Table 1. Most respondents (84%) were aged between
25–64 years and 57% were female—this is consistent with the gender distribution of pharmacists
registered in Australia [19]. The majority of respondents practiced in a metropolitan rather than
rural area (75% vs 25%), and the most commonly reported primary patient care role was community
pharmacy (65%), followed by conducting Home Medicines Reviews (HMR) or Residential Medication
Management Reviews (RMMR) (17%), hospital pharmacy (14%) and general practice clinics (3%).
Nearly two-thirds of respondents had current access to MHR (65%); others reported they did not
have access (24%) or were unsure if they had access (11%). Of those with access to MHR, 41% had
accessed MHR between 1–5 times during the past month, while 17% had accessed MHR 6–10 times.
Most respondents (63%) indicated that they were likely to use MHR within the next 12 months.
Table 1. Demographic characteristics (n = 63).
Characteristic n (%)
Age in years, n (%)
<25 4 (6)
25–34 17 (27)
35–44 16 (25)
45–54 12 (19)
55–64 8 (13)
65+ 3 (5)
Prefer not to answer 3 (5)
Gender *
Male 26 (41)
Female 36 (57)
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Table 1. Cont.
Characteristic n (%)
State of practice *
ACT 10 (16)
NSW 22 (35)
NT 2 (3)
QLD 10 (16)
SA 1 (2)
TAS 3 (5)
WA 7 (11)
VIC 5 (8)
Area of practice
Metropolitan 47 (75)
Rural 16 (25)
* Percentages reported are actual and do not equal 100% due to missing data/unanswered questions. ACT: Australian
Capital Territory; NSW: New South Wales; NT: Northern Territory; QLD: Queensland; SA: South Australia; TAS:
Tasmania; WA: Western Australia; VIC: Victoria.
3.1. Benefits
Responses to statements related to potential benefits of MHR are displayed in Table 2. The majority
of respondents agreed (either somewhat or strongly) that use of MHR would help with continuity of
care (90%) and improve the safety (71%) and quality (75%) of the care they provided. Over half of the
respondents (57%) agreed that use of MHR has the potential to reduce medication errors during the
dispensing process. Most agreed that use of MHR could improve their professional relationship with
patients (57%) and general practitioners (59%). We observed that respondents who used MyHR more
frequently in the past month, were more likely to agree that MHR ‘will help with continuity of care’
(Kendall’s tau-c p = 0.001). Other demographic factors did not appear to be significantly influence the
perceived benefits.
Table 2. Perceived benefits of the use of My Health Record.
Statement
Response, n (%)
Strongly
Agree
Somewhat
Agree
Neither Agree
Nor Disagree
Somewhat
Disagree
Strongly
Disagree
MHR will help with
continuity of care 31 (49) 26 (41) 5 (8) 0 (0) 1 (2)
MHR reduces medication
errors when dispensing 13 (21) 23 (36) 17 (27) 8 (13) 2 (3)
MHR improves the safety
of care I provide 21 (33) 24 (38) 15 (24) 3 (5) 0 (0)
MHR improves the quality
of patient care I provide 22 (35) 25 (40) 11 (17) 3 (5) 2 (3)
MHR improves my
professional relationship
with my patients
19 (30) 17 (27) 20 (32) 5 (8) 2 (3)
MHR improves my
professional relationship
with general practitioners
15 (24) 22 (35) 17 (27) 7 (11) 2 (3)
Abbreviations: MHR, My Health Record.
3.2. Barriers
Participant responses to statements related to potential barriers to MHR use are displayed in
Table 3. Eighty-one percent of responding pharmacists reported that patients’ concerns about privacy
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or confidentiality were likely (either extremely likely or somewhat likely) to act as a barrier to the use
of MHR. Pharmacists’ own concerns about privacy and confidentiality were also considered likely to
act as a barrier by 46% of respondents. Some respondents reported a lack of IT support (30%), training
to set up and access the system (41%), and training to enable users to confidently use the system (41%)
as likely barriers. A proportion of respondents (21%) identified use of MHR as being likely to interfere
with existing dispensing processes, while over 40% reported this as unlikely (somewhat or extremely
unlikely) to act as a barrier. Almost half of respondents (48%) expressed that it was ‘neither likely nor
unlikely’ that their workplace would not promote use of the system.
Table 3. Barriers to use of My Health Record.
Statement
Response, n (%)
Extremely
Likely
Somewhat
Likely
Neither Likely
Nor Unlikely
Somewhat
Unlilkely
Extremely
Unlikely
I am concerned about
privacy/confidentiality issues
of MHR *
20 (32) 9 (14) 6 (9) 15 (24) 12 (19)
My patients are concerned
about privacy/ confidentiality
issues of MHR
25 (40) 26 (41) 9 (14) 3 (5) 0 (0)
My workplace does not
promote the use of this system 3 (5) 11 (17) 30 (48) 8 (13) 11 (17)
I do not have the appropriate
IT support 9 (14) 10 (16) 15 (24) 13 (21) 16 (25)
I have not received training to
set up the access to the system 17 (27) 9 (14) 8 (13) 14 (22) 15 (24)
I have not received training to
confidently use the system 15 (24) 11 (17) 9 (14) 11 (17) 17 (27)
It interferes with the existing
dispensing processes 5 (8) 8 (13) 22 (35) 13 (21) 15 (24)
I do not believe the time spent
provides a significant value
gained
6 (9) 12 (19) 12 (19) 16 (25) 17 (27)
It is not within my position
description in my current
professional role
2(3) 6 (9) 14 (22) 12 (19) 29 (46)
* Percentages reported are actual and do not equal 100% due to missing data/unanswered questions. Abbreviations:
MHR, My Health Record. Participant who identified that they were encountering issue such as lack of IT support and
lack of training to setup MHR, were less likely to use MyHR (Kendall’s tau-c, p = 0.010 and p < 0.0001, respectively).
3.3. Concerns
A review of the statements with possible concerns and participant responses are displayed
in Table 4. Two-thirds of respondents had concerns about the accuracy of information contained
within MHR and almost half (44%) had concerns about the security of information in the system.
Thirty-eight percent agreed that they were concerned about the system not being user-friendly to
navigate and find information, while 30% agreed that MHR would slow down the dispensing process.
Respondents whose primary practice were hospital or GP clinic expressed greater concerns about the
accuracy of MHR data (Kruskal–Wallis test, p = 0.016); and those pharmacists whose primary roles
were HMR/RMMR providers or in GP clinics had greater concerns about the security of MHR data
(Kruskal–Wallis test, p = 0.007). Additionally, respondents that had greater concern about the accuracy
of MHR information were less likely to use the system (Kendall’s tau-c, p = 0.009).
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Table 4. Potential concerns to use of My Health Record.
Statement
Response, n (%) *
Strongly
Agree
Somewhat
Agree
Neither Agree
Nor Disagree
Somewhat
Disagree
Strongly
Disagree
I have concerns about the
security of information within
the MHR system
18 (29) 10 (16) 10 (16) 15 (24) 10 (16)
I have concerns about
accuracy of information
within the MHR system
19 (30) 23 (36) 5 (8) 11 (17) 5 (8)
MHR slows me down when
dispensing 12 (19) 7 (11) 24 (38) 10 (16) 10 (16)
It is not user-friendly to
navigate MHR to find the
information I want
10 (16) 14 (22) 28 (44) 8 (13) 3 (5)
* Percentages reported may not equal 100% due to rounding. Abbreviations: MHR, My Health Record.
3.4. Overall Satisfaction
Overall satisfaction with MHR varied, with most being satisfied (extremely or somewhat; 48%),
a lesser proportion reported they were neither satisfied or dissatisfied (33%), and the remaining
respondents reported dissatisfaction (extremely or somewhat; 19%). Younger pharmacists (age < 45)
were more satisfied with MHR than older pharmacists (age > 45) (Kruskal–Wallis test, p = 0.032).
3.5. Other Comments
Respondents were asked about the characteristics of MHR that required improvement, using a
free-text response. The following themes emerged: privacy and security of patient data; improving the
user interface and ease of use; training and the provision of appropriate, timely support for system
users; and further improvements in integration with dispensing software.
4. Discussion
This study explored the perspectives of a sample of pharmacists regarding the use of MHR at an
early stage of widespread re-launch of MHR in Australia. Findings indicated a reasonably high level of
awareness and access to MHR among the pharmacists surveyed. Most respondents believed that MHR
is likely to be beneficial in many aspects such as reducing errors, improving patient care, enhancing
collaboration with health professionals and improving patient satisfaction. Younger pharmacists had a
higher satisfaction rate with MHR overall, which may be due to greater familiarity with electronic
communication. However, pharmacists mainly from hospital pharmacies or general practice clinics,
expressed concerns about accuracy and completeness of the information, which is essential in achieving
the full benefit of MHR. We believe this might be due to the amount of information available in MHR
at present. While this information is more comprehensive than records kept at community pharmacies,
it is less comprehensive than records kept at hospital or general practice clinics.
More than half of the pharmacists surveyed agreed that use of MHR could potentially reduce
medication errors when dispensing and might improve the safety of the care provided. Given that
one of the primary roles of pharmacists is to facilitate the safe delivery of medication and minimise
medication misadventure [21], the use of MHR may offer benefits that are closely aligned with
pharmacists’ core professional activities. Greater access to an integrated patient record has the potential
to improve safety outcomes, particularly during care transitions and for patients with increased risk of
medication-related problems, such as older people [22]. Previous evidence has demonstrated that use of
EHRs in the hospital setting can reduce medication-related problems [23]. In the community pharmacy
setting, a lack of hospital discharge communication acts as a barrier to medication reconciliation [24],
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which can be reduced with use of EHRs [25]. Community pharmacies are accessible and highly utilised
by health care consumers, with one large study finding that the first contact with a health care provider
following hospital discharge was with a community pharmacist [26]. Yet, routine communication
following hospital discharge is low, and community pharmacists have relied on patients relaying
medication information. Medication-related problems that occur when patients transition between
care settings may be reduced through improved interprofessional collaboration and the use of a shared
system [7]. A 2018 study that examined the use of EHRs to facilitate a comprehensive medication
review following hospital discharge, found a significant reduction in hospital readmission in patients
who underwent the review following discharge compared to those who did not [27].
Rather than relying on patient recall alone, the use of patient-entered Health Summaries and
pharmacist-entered information in a pharmacist shared medicines list on MHR may also contribute
to a reduction in drug interactions between prescription and non-prescription medication. Greater
access to relevant patient information creates opportunities for pharmacists to contribute to optimised
treatment [22]. Digital information transfer such as through an EHR improves the speed and accuracy
of information, and was considered the preferred mode of receiving information in a 2018 study of
pharmacists [24].
The appropriate management of patient confidentiality, privacy and data security is essential
to the successful implementation of EHRs [28]. Given the sensitive nature of personal health data
and its potential for misuse, it is unsurprising that pharmacists in this study identified these issues
as potential barriers to the widespread adoption of MHR. While almost half of respondents reported
their own concerns related to patient privacy and confidentiality as a likely barrier to use, even more
(81%) considered patient-related concerns about privacy and confidentiality a barrier. The security of
patient health records and trust in the management of health-related personal data remain key issues
to the adoption of EHRs, with previous studies finding that concerns about privacy, confidentiality and
data security were common among a range of users including general practitioners, nurses, and allied
health practitioners [14,15,29]. Pharmacists’ perceptions of patient-related concerns limiting the use of
MHR are not unfounded, with patient concerns about privacy associated with use of personal health
records previously identified [12,30]. Yet, the concept of personally-controlled EHRs has been well
received by some consumers who see the potential for improved communication with providers, better
quality healthcare and improved ability to self-manage their health [10,12,15]. With more than 90% of
Australians registered for an MHR (following the voluntary opt-out process), as of early 2019 [31], it is
likely that perceptions about patient-related concerns will change over time.
In a systematic review of user perspectives of factors influencing implementation of EHR, technical
aspects were identified as one of the most common barriers [32]. Similarly, ease of use and technical
concerns have been identified as barriers to MHR use among general practitioners, nurses and other
allied health professionals [14], while a perceived increase in workload and time-related demands
were barriers to pharmacists [33] and other health care providers [14]. Respondents in the present
study indicated that a lack of training during setup, along with a lack of training to ensure users could
confidently use MHR, was likely to act as a barrier to the use of MHR. Pharmacists also expressed
concerns that the use of MHR is likely to interfere with the existing dispensing processes and may slow
down the workflow. This is particularly important for community pharmacies, operating as small
businesses. Perceived ease of use has been identified as a strong predictor of intention to use EHRs [34]
and can facilitate implementation [32,35]. Findings revealed that improving the integration between
existing dispensing software and MHR was important for pharmacists in this study.
Two-thirds of pharmacists surveyed in this study agreed that the accuracy of the information
contained within MHR was a concern. This could be potentially related to unfamiliarity with the MHR
system, limitations of incomplete records and where information had been omitted or was concealed
from view. From a pharmacist perspective, especially in community pharmacy, extra information
available within the MHR may shed further light on the medical conditions and other relevant
information about a patient. Similar concerns were reported in a qualitative study of Australian
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pharmacists before the relaunch of MHR [33]. The Pharmaceutical Society of Australia briefly addresses
issues of completeness in their My Health Record Guidelines for Pharmacists and states that MHR
“cannot be assumed to be a complete record” [36]. Personal control over what is contained in an
individual’s MHR and what is subsequently shared with health care providers is a key feature of MHR.
While this level of patient control may have disadvantages and the absence of all information may
influence the healthcare provider’s decision making, it offers active users a level of protection, which is
important given the range of sensitive information a record may contain and the varied information
needs of the healthcare providers. This might be minimised if there is an indicator showing where
information is removed.
In order to optimize MHR and further facilitate the use of MHR in pharmacies, stakeholders’
concerns should be considered. To address the concerns about accuracy of data and user-friendliness,
we recommend MHR to adopt standardization, integration, and synchronization of data with existing
systems including pharmacy dispensing systems and hospital digital health records [37–39]. We also
recommend programs to encourage pharmacists to contribute towards ongoing improvement of MHR
and improve pharmacist partnership in utilizing MHR, such as updating patient-level information and
incorporating interventions or recommendations in MHR [38,40,41].
5. Limitations
The study reflects on findings from a relatively small sample (n = 63) out of a total of 30,000
registered pharmacists in Australia. It was unknown how many pharmacists actively used MHR
or whether the survey was accessible to all Australian pharmacists. Additionally, respondents were
mainly from the metropolitan areas. Hence, overall results may not be generalizable. Since the MHR
had been recently relaunched, at the time of the survey, some respondents had not yet accessed MHR
in their workplace and user perspectives may change with greater exposure to the system.
6. Conclusions
This study explored the perspectives of pharmacists regarding the use of MHR at an early stage
of widespread re-launch of MHR in Australia. Most pharmacists identified benefits of MHR that
were central to their role, including improved medication safety, continuity of care, and quality of
care. The results suggest a need to continue to manage concerns related to privacy and data security,
and to ensure adequate provision of user support and education surrounding the ability to integrate
use of MHR with existing workflows and software. Further research is needed in the future with
larger sample size to determine how the use of MHR by pharmacists may affect clinical outcomes and
whether the perspectives of pharmacists change over time when the use of MHR is further expanded.
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